The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant attention within the British Isles, prompting a notable shift in peptide trends. Obtaining these medications remains a complex landscape, with NHS approval currently limited and private clinics offering prescriptions at a higher cost . Concerns are being rai